Helius Medical Technologies, Inc. Profile
Industry
Medical - DevicesSector
HealthcareNumber of Employees
22Helius Medical Technologies's Business Model
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
About Helius Medical Technologies
Website: https://heliusmedical.com
CEO (Chief Executive Officer): Mr. Dane Carl Andreeff
IPO date: 2014-06-27
Contact
Country: US
Address: 642 Newtown Yardley Road
City: Newtown
State: PA
Phone: 215 944 6100
Zip Code: 18940
Other
CIK: 0001610853
ISIN: US42328V8019
CUSIP: 42328V504
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
